Statement of changes in beneficial ownership of securities



>




X0306


4


2021-05-28


0



0001270073


INTERCEPT PHARMACEUTICALS, INC.


ICPT





0001559569


Pruzanski Mark




C/O INTERCEPT PHARMACEUTICALS, INC.


10 HUDSON YARDS, FLOOR 37


NEW YORK


NY


10001






1


0


0


0










The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Intercept Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

Intercept Pharmaceuticals's Chief Qual. Officer & SVP Ops. just disposed of 2,455 shares - Jan. 13, 2022
Departure of Directors or Certain - Jan. 10, 2022
Statement of changes in beneficial ownership of securities - Jan. 4, 2022
SVP of Intercept Pharmaceuticals just disposed of 2,455 shares - Jan. 4, 2022
Intercept Pharmaceuticals's Chief Human Resources Officer just disposed of 1,712 shares - Jan. 4, 2022

Auto Refresh

Feedback